Latest From Skadden

  • A Dialogue With Corporate Counsel: Skadden’s Eighth Annual Pharmaceutical and Medical Device Seminar
    Skadden, Arps, Slate, Meagher & Flom LLP
    John T. Bentivoglio, Jennifer L. Bragg, Maya P. Florence, Michael K. Loucks, Gregory M. Luce, Avia M. Dunn, Alexandra M. Gorman
    On October 30, 2018, Skadden hosted its Eighth Annual Pharmaceutical and Medical Device Seminar, which focused on U.S. enforcement issues faced by companies in the life sciences industry.
  • Potential Outcomes of Apple v Pepper
    New York Law Journal
    Shepard Goldfein, Karen Hoffman Lent

    Partners Shepard Goldfein and Karen Hoffman Lent look at four possible outcomes for Apple v. Pepper, the potentially landmark antitrust case in which iPhone owners are suing Apple for monopolizing, or attempting to monopolize, the market for iPhone apps.

  • Skadden Discusses Proposed Updates to Banking Rules for Derivative-Contract Exposure
    The CLS Blue Sky Blog
    William J. Sweet, Jr., Mark D. Young, James A. Frazer, Collin P. Janus, Rachel Kaplan Reicher

    Partners William Sweet and Mark Young and counsel James Frazer, Collin Janus and Rachel Kaplan Reicher analyze a proposed banking regulation that, if adopted, should provide regulatory capital relief for certain derivative exposures.

Upcoming Speaking Engagements